Drug-induced ototoxicity

References

• Aguilar-Markulis N. V., Beckley S., Friore R., Mettlin C. Auditory toxicity effects of long term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients. Journal of Surgery and Oncology 1981; 16: 111–123
   PubMed Web of Science ®Google Scholar
• Ajodhia J. M., Dix M. R. Drug induced deafness and its treatment. Practitioner 1976; 216: 561–570
   PubMedGoogle Scholar
• Aursnes J. Cochlear damage from chloro-hexidine in guinea pigs. Acta Otolaryngologica 1981a; 92: 259–271
   PubMed Web of Science ®Google Scholar
• Aursnes J. Vestibular damage from chlorohexide in guinea pigs. Acta Otolaryngologica 1981b; 92: 89–100
   PubMed Web of Science ®Google Scholar
• Aursnes J. Ototoxic effect of quarternary ammonium compounds. Acta Otolaryngologica 1982a; 93: 421–433
   PubMed Web of Science ®Google Scholar
• Aursnes J. Ototoxic effect of iodine disinfectants. Acta Otolaryngologica 1982b; 93: 219–226
   PubMed Web of Science ®Google Scholar
• Barker P. A., Ashcroft G. W., Burns J. K. Imipramine in chronic depression. Journal of Mental Science 1960; 106: 1447–1451
   PubMed Web of Science ®Google Scholar
• Bellucci R. J., Wolff D. Tissue reaction following reconstruction of the oval window in experimental animals. American Otology (St Louis) 1960; 69: 517–539
   PubMedGoogle Scholar
• Beyer K. H., Baer J. E., Michealson J. K., Russoh F. Renotropic characteristics of ethacrynic acid: a phenoxyacetic saluretic diuretic agent. Journal of Pharmacology and Experimental Therapeutics 1965; 147: 1–22
   PubMed Web of Science ®Google Scholar
• Bicknell P. G. Sensorineural deafness following myringoplasty operations. Journal of Laryngology and Otology 1971; 85: 957–961.
   PubMedGoogle Scholar
• Black F. O., Myers E. N., Schramm V. L., Johnson J., Sigler B., Thearle P. B., Burn D. S. Cisplatin vestibular ototoxicity: preliminary report. Laryngoscope 1982; 92: 1363–1368
   PubMed Web of Science ®Google Scholar
• Bosher S. K. The nature of the ototoxic actions of ethacrynic acid upon the mammalian endolymph system. I. Functional aspects. Acta Otolaryngologica 1980a; 89: 407–418
   PubMed Web of Science ®Google Scholar
• Bosher S. K. The nature of the ototoxic actions of ethacrynic acid upon the mammalian endolymph system. II. Structural-functional correlates in the stria vascularis. Acta Otolaryngologica 1980b; 90: 40–54
   PubMed Web of Science ®Google Scholar
• Boston Collaborative Program Drug Surveillance. Drug induced deafness: a co-operative study. Journal of the American Medical Association 1973; 244: 515–516
   Google Scholar
• Bourke E. Frusemide, bumetanide and oto-toxicity. Lancet 1976; i: 917–918
   Google Scholar
• British Medical Journal. Leading article: side effects of practalol. British Medical Journal 1975; 2: 577–578
   PubMedGoogle Scholar
• Brown R. D., McElwee T. W., Jr. Effects of intra-arterially and intravenously administered etha-crynic acid and furosemide on cochlear Nl in cats. Toxicology and Applied Pharmacology 1972; 22: 589–594
   PubMed Web of Science ®Google Scholar
• Brown R. D. Comparison of the cochlear tox-icity of sodium ethacrynate, furosemide, and the cys-teine adduct of sodium ethacrynate in cats. Toxicology and Applied Pharmacology 1975a; 31: 270–282
   PubMed Web of Science ®Google Scholar
• Brown R. D. Cochlear Nl depression produced by the new ‘loop’ diuretic, bumetanide, in cats. Neuro-pharmacology 1975b; 14: 547–553
   Google Scholar
• Brown R. D., Feldman A. M. Pharmacology of hearing and ototoxicity. Annual Review of Pharmacology and Toxicology 1978; 18: 233–252
   PubMed Web of Science ®Google Scholar
• Brummett R. E., Traynor J., Brown R., Himes D. Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngologica 1975; 80: 86–92
   PubMed Web of Science ®Google Scholar
• Brummett R. E., Smith C. A., Ueno Y., Cameron S., Richter R. The delayed effects of etha-crynic acid on the stria vascularis of the guinea pig. Acta Otolaryngologica 1977; 83: 98–112
   PubMed Web of Science ®Google Scholar
• Brummett R. E. Drug induced ototoxicity. Drugs 1980; 19: 412–428
   PubMed Web of Science ®Google Scholar
• Brummett R. E., Pox K. E. Studies of amino-glycoside ototoxicity in animal models. The Aminoglycosides. Microbiology, Clinical Use and Toxicity, A. Whelton, H. C. Neu. Marcel Dekker Inc., New York 1982; 419–451
   Google Scholar
• Chapman P. Rapid onset hearing loss after cisplatinum therapy: case reports and literature review. Journal of Laryngology and Otolaryngology 1982a; 96: 159–162
   PubMed Web of Science ®Google Scholar
• Chapman P. Naproxen and sudden hearing loss. Journal of Laryngology and Otolaryngology 1982b; 96: 163–166
   PubMed Web of Science ®Google Scholar
• Crifó S. Ototoxicity of sodium ethacrynate in the guinea pig. Archives of Otorhinolaryngology 1973; 206: 27–38
   Google Scholar
• Cummings C. W. Experimental observations on the ototoxicity of nitrogen mustard. Laryngoscope 1968; 78: 503–508
   Google Scholar
• Dal I., Edsmyr F., Stahle J. Bleomycin therapy and ototoxicity. Acta Otolaryngologica 1973; 75: 323–324
   PubMed Web of Science ®Google Scholar
• Desrochers C. S., Schacht J. Neomycin concentrations in inner ear tissues and other organs of the guinea pig after chronic drug administration. Acta Otolaryngologica 1982; 93: 233–236
   PubMed Web of Science ®Google Scholar
• Dewar W. A., Mann H. M. Chloroquinine in lupus erythematosus. Lancet 1954; i: 780–781
   Google Scholar
• Dick-Smith J. B. Lbuprofen, aspirin and placebo in the treatment of rheumatoid arthritis—a double-blind clinical trial. Medical Journal of Australia 1969; 22: 853–859
   Google Scholar
• Engström H. Cited by Ballantyne, J. (1973). Ototoxicity: a clinical review. Audiology 1972; 12: 325–336
   Google Scholar
• Ernston S. Ethacrynic acid-induced hearing loss in guinea pigs. Acta Otolaryngologica 1972; 73: 476–483
   PubMed Web of Science ®Google Scholar
• Estrem S. A., Babin P. W., Ryu J. H., Moore K. C. Cisdiamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngology and Head and Neck Surgery 1981; 89: 638–645
   PubMed Web of Science ®Google Scholar
• Fausti S. A., Schecter M. A., Rappaport B. Z., Frey R. H., Mass R. E. Early detection of cisplatin ototoxicity. Cancer 1984; 53: 224–231
   PubMed Web of Science ®Google Scholar
• Federspil P. Pharmacokinetics of aminoglycoside antibiotics in the perilymph. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown and Company, Boston 1981; 99–108
   Google Scholar
• Finegold S. M. Toxicity of kanamycin in adults. Annals of the New York Academy of Science 1966; 132: 942–956
   PubMed Web of Science ®Google Scholar
• Fleischman R. W., Standnicki S. W., Ethier M. F., Schaeppi U. Ototoxicity of cis-dichloro-diammineplatinum (II) in the guinea pig. Toxicology and Applied Pharmacology 1975; 33: 320–332
   PubMed Web of Science ®Google Scholar
• Gallagher K. L., Jones J. K. Furosemide-induced ototoxicity. Annals of Internal Medicine 1979; 91: 744–745
   PubMed Web of Science ®Google Scholar
• Garcia-Guiroga J., Norris C. H., Glade L., Bryant G. M., Tachibana M., Guth P. S. The relationship between kanamycin ototoxicity and glucose transport. Research Communications in Chemical Pathology and Pharmacology 1978; 22: 535–547
   PubMedGoogle Scholar
• Glorig A., Fowler E. P., Jr. Tests for labyrinth function following streptomycin therapy. Annals of Otology 1947; 56: 379–394
   PubMed Web of Science ®Google Scholar
• Gold A., Wilpizeski C. R. Studies in auditory adaptation: II. Some effects of sodium salicylate on evoked auditory potentials in cats. Laryngoscope 1966; 76: 674–685
   PubMed Web of Science ®Google Scholar
• Graham G. G., Champion G. D., Day R. O., Paull P. D. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis. Clinical Pharmacology and Therapeutics 1977; 22: 410–420
   PubMed Web of Science ®Google Scholar
• Hammond V. Perceptive deafness in adults. British Medical Journal 1970; 2: 523–525
   PubMed Web of Science ®Google Scholar
• Hanzelik E., Peppercorn M. Deafness after ethacrynic acid. Lancet 1969; i: 416.
   Google Scholar
• Harpur E. S., Jabeen F., Kingston R., Gonda I., Brammer K. W., Gregory M. H. Single and multiple dose pharmacokinetics of ribostamycin in serum and perilymph of guinea pigs in relation to its low toxicity. Organ-directed Toxicity Chemical Indices and Mechanisms, S. S. Brown, D. S. Davies. Pergamon Press, Oxford 1981; 31–36
   Google Scholar
• Hart C. W., Naunton R. F. The ototoxicity of chloroquinine phosphate. Archives of Otolaryngology 1964; 80: 407–412
   PubMed Web of Science ®Google Scholar
• Hawkins J. E., Jr. Antibiotics and the inner ear. Transactions of the American Academy of Opthal-mology and Otolaryngology 1959; 63: 206–218
   PubMedGoogle Scholar
• Hawkins J. E., Jr., Johnsson L. G., Preston R. E. Cochlear microvasculature in normal and damaged ears. Laryngoscope 1972; 82: 1091–1104
   PubMed Web of Science ®Google Scholar
• Hawkins J. E., Jr. Ototoxic mechanisms. Audiology 1973; 12: 383–393
   PubMedGoogle Scholar
• Hawkins J. E., Jr. Drug ototoxicity. Handbook of Sensory Physiology, W. D. Keidel, W. D. Neff. Springer-Verlag, Berlin 1976; vol. 5: 707–748, part 3
   Google Scholar
• Hawkins J. E., Jr., Johnsson L. G. Animal models in the study of ototoxic hearing loss. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown and Company, Boston 1981; 175–195
   Google Scholar
• Helson L., Okonkwo E., Anton L., Ovitkovic E. Cis-platinum ototoxicity. Clinical Toxicology 1978; 13: 469–478
   PubMed Web of Science ®Google Scholar
• Hennebert D., Fernández C. Ototoxicity of quinine in experimental animals. Archives of Oto-laryngocology 1959; 70: 321 333.
   Web of Science ®Google Scholar
• Hollister L. E. Measuring Measurin: problems of oral prolonged-action medications. Clinical Pharmacology and Therapeutics 1972; 13: 1–5
   PubMed Web of Science ®Google Scholar
• Humes H. D., Weiner N. H., Schacht J. The biochemical pathology of aminoglycoside-induced nephro and ototoxicity. Nephrotoxicily, Ototoxicity of Drugs, J. P. Fillastre. Inserm and University of Rouen. 1981; 333–343
   Google Scholar
• Huskisson E.C, Wojtulewski J. A., Berry H., Scott J., Dudley Hart F. Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. British Medical Journal 1977; 1: 176–180
   Google Scholar
• Jackson G. G., Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. Journal of Infectious Diseases 1971; 124: 130–137, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Jager B. V., Alway R. The treatment of acute rheumatic fever with large doses of sodium salicylate with special reference to dose management and toxic manifestations. American Journal of Medical Science 1946; 211: 273–285
   PubMed Web of Science ®Google Scholar
• Jao R. L., Jackson G. G. Gentamicin sulphate, new antibiotic against gram-negative bacilli. Laboratory, pharmacological and clinical evaluation. Journal of the American Medical Association 1964; 189: 817–822.
   PubMed Web of Science ®Google Scholar
• Jarvis J. F. A case of unilateral permanent deafness following acetylsalicylic acid. Journal of Laryngology and Otology 1966; 80: 318–320
   PubMedGoogle Scholar
• Johnsson L. G., Hawkins J. E., Jr. Strial atrophy in clinical and experimental deafness. Laryngoscope 1972; 82: 1105–1125
   PubMed Web of Science ®Google Scholar
• Johnsson L. G., Hawkins J. E., Jr., Kingsley T.C, Black F. O., Matz G. J. Aminoglycoside-induced cochlear pathology in man. Acta Otolaryn-gologica 1981; 383: 1–19, Suppl.
   Google Scholar
• Kahlmeter G., Dahlager J. I. Aminoglycoside toxicity a review of clinical studies produced between 1975 and 1982. Journal of Antimicrobial Chemotherapy 1984; 13 (Suppl. A): 9–22
   PubMed Web of Science ®Google Scholar
• Kaloyanides G. J., Pastoriza-Munoz E. Amino-glycoside nephrotoxicity. Kidney International 1980; 8: 571–582
   Google Scholar
• Kapur Y. P. Ototoxicity of acetylsalicylic acid. Archives of Otolaryngology 1965; 81: 134–138
   PubMed Web of Science ®Google Scholar
• Keene M., Hawkes M., Barber H. O., Farkashidy J. Histopathological findings in critical gentamicin olotoxicity. Archives of Otolaryngology 1982; 108: 65–70
   PubMed Web of Science ®Google Scholar
• Kinsella T. D., Mackenzie K. R., Kim S. O., Johnsson L. G. Evaluation of indomethacin by a controlled crossover technique in 30 patients with ankylosing spondylitis. Canadian Medical Association Journal 1967; 96: 1454–1459
   PubMed Web of Science ®Google Scholar
• Kusakari J., Ise I., Comegys T. H., Thalmann I., Thalmann R. Effect of ethacrynic acid, furo-semide and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascu-laris. Laryngoscope 1978; 88: 12–37
   PubMed Web of Science ®Google Scholar
• Lancet. Editorial: Ear drops. Lancet 1976; i: 896
   Google Scholar
• Lloyd-Mostyn R. H. Tinnitus and propranolol. British Medical Journal 1969; 2: 766
   PubMed Web of Science ®Google Scholar
• Maher J. E., Schreiner G. E. Studies on ethacrinic acid in patients with refractory oedema. Annals of Internal Medicine 1965; 62: 15–29
   PubMed Web of Science ®Google Scholar
• Marks S. C., Schacht J. Effects of ototoxic diuretics on cochlear Na+/K+-ATPase and adenylate cyclase. Scandinavian Audiology. 1981; 131–137., (Suppl. 14)
   Google Scholar
• Mathog R. H., Klein W. J., Jr. Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uraemia. New England Journal of Medicine 1969; 280: 1223 1224.
   PubMed Web of Science ®Google Scholar
• Mathog R. H., Thomas V. G., Hudson W. R. Ototoxicity of new and potent diuretics. Archives of Otolaryngology 1970; 92: 7–13
   PubMed Web of Science ®Google Scholar
• McCabe P. A., Dey F. L. The effect of aspirin upon auditory sensitivity. Annals of Otology 1965; 74: 312 375.
   Web of Science ®Google Scholar
• McClcan C. E., Stoughton P. V., Kagery K. S. Experiences with beta-adrenergic blockade. Vascular Surgery 1967; 1: 108–126
   Google Scholar
• McDowell B. Patterns of cochlear degeneration following gentamicin administration in both old and young guinea-pigs. British Journal of Audiology 1982; 16: 123
   PubMedGoogle Scholar
• McKenzie I. F. C, Matthew T. H., Bailie M. J. Peritoneal dialysis in the treatment of quinine overdose. Medical Journal of Australia 1968; 1: 58–59
   PubMedGoogle Scholar
• McKinna A. J. Quinine induced hypoplasia of the optic nerve. Canadian Journal of Ophthalmology 1966; 1: 261–266.
   PubMedGoogle Scholar
• McRiwcthcr W. D., Mangi R. J., Serpick A. A. Deafness following standard intravenous dose of ethacrynic acid. Journal of the American Medical Association 1971; 216: 795–798
   Web of Science ®Google Scholar
• Miller R. R. Deafness due to plain and long acting aspirin tablets. Journal of Clinical Pharmacology 1978; 18: 468–471
   PubMed Web of Science ®Google Scholar
• Miller R. R., Jick H. Acute toxicity of aspirin in hospitalized medical patients. American Journal of Medical Science 1977; 274: 271–279
   PubMed Web of Science ®Google Scholar
• Morizono T., Sikora M. A. Ototoxicity of topically applied Povidone-iodine preparations. Archives of Otolaryngology 1982; 108: 210–213
   PubMed Web of Science ®Google Scholar
• Myers E. N., Bernstein J. M. Salicylate ototoxicity. A clinical and experimental study. Archives of Otolaryngology 1965; 82: 483–493
   PubMed Web of Science ®Google Scholar
• Nakai Y., Konishi K., Chang K.C, Chashi Mori-saki K.N., Minowa Y., Morimoto A. Ototoxicity of the anti-cancer drug cisplatin. Acta Oto-laryngologica 1982; 93: 227–232
   PubMed Web of Science ®Google Scholar
• Nilges T. C., Northern J. L. Iatrogenic hearing loss. Annals of Surgery 1971; 173: 281–289
   PubMed Web of Science ®Google Scholar
• Northington P. Syndrome of bilateral vestibular paralysis and its occurrence from streptomycin therapy. Archives of Otolaryngology 1950; 52: 380–396
   PubMed Web of Science ®Google Scholar
• Orsulakova A., Schacht J. A biochemical mechanism of the ototoxic interaction between neo-mycin and ethacrynic acid. Acta Otolaryngologica 1981; 93: 43–48
   Web of Science ®Google Scholar
• Paloheimo S., Thalmann R. Influence of ‘loop’ diuretics upon Na+/K+-ATPase and adenylate cyclase of the stria vascularis. Archives of Otorhino-laryngology 1977; 217: 347–359
   PubMed Web of Science ®Google Scholar
• Peiterscn E. Disturbances in the central vestibular system after oral contraceptives. Journal of Laryngology and Otology 1969; 83: 725–729
   PubMedGoogle Scholar
• Piel I. J., Meyer D., Perlia C., Wolfe V. Effects of cis-dichlorodiammineplatinum II (NSC-119875) on hearing function in man. Cancer and Chemotherapy Reports 1974; 58: 871–875
   PubMedGoogle Scholar
• Pike D. A., Bosher S. K. The time course of the strial changes produced by intravenous furose-mide. Hearing Research 1980; 3: 79 89.
   PubMed Web of Science ®Google Scholar
• Pillay V. K. G., Schwartz F. D., Aimi K., Kark R. M. Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1969; i: 77–79
   Google Scholar
• Pinals R. S., Frank S. Relative efficacy of indomethacin and acetylsalicylic acid in rheumatoid arthritis. New England Journal of Medicine 1967; 276: 512–514
   PubMed Web of Science ®Google Scholar
• Porter J., Jick H. Drug induced anaphylaxis, convulsions, deafness and cxtrapyramidal symptoms. Lancet 1977; i: 587–588
   Google Scholar
• Prazma J., Browder J. P., Fischer N. D. Ethacrynic acid ototoxicity potentiation by kana-mycin. Annals of Otology 1974; 83: 111–118
   PubMed Web of Science ®Google Scholar
• Prazma J., Ferguson S. D., Kidivell S. A., Garrison H. G., Drake A., Fischer J. Alteration of ominoglycosidc antibiotic ototoxicity by hyper and hypohydration. American Journal of Otolaryngology 1981; 2: 299–306
   PubMedGoogle Scholar
• Quick C. A., Hoppe W. Permanent deafness associated with furosemide administration. Annals of Otology 1975; 84: 94–101
   PubMed Web of Science ®Google Scholar
• Racy J., Ward-Racy E. A. Tinnitus in imi-pramine therapy. American Journal of Psychiatry 1980; 137: 854–855
   PubMedGoogle Scholar
• Rahm W. E., Jr., Strother W. F., Crump J. F., Parker D. E. The effect of anesthetics upon the ear. Annals of Otology 1962; 71: 116–123
   PubMedGoogle Scholar
• Reddel R. R., Kefford R. F., Grant J. M., Coates A. S., Fox R. M., Tattershall M. H. N. Ototoxicity in patients receiving cisplatinum: importance of dose and method of drug administration. Cancer Treatment Reports 1982; 66: 19–24
   PubMedGoogle Scholar
• Richards S. H. Ototoxicity of absorbable gelatin sponge. Proceedings of the Royal Society of Medicine 1973; 66: 196
   Google Scholar
• Robin I. G. Sensorineural deafness. Scott-Brown's Diseases of the Ear, Nose and Throat, 3rd edn, J. Ballan-tyne, J. Groves. Butterworth, London 1971; 419–474
   Google Scholar
• Robinson R. G. Indomethacin in rheumatic disease: a clinical assessment. Medical Journal of Australia 1965; 1: 266–269
   PubMedGoogle Scholar
• Russell N. J., Fox K. E., Brummett R. E. Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Acta Oto-laryngologica 1979; 88: 369–381
   PubMed Web of Science ®Google Scholar
• Schaefer S. D., Wright C. G., Post J. D., Frenkel E. P. Cis platinum vestibular toxicity. Cancer 1981; 47: 857–859
   PubMed Web of Science ®Google Scholar
• Schentag J. J., Jusko W. J., Vance J. W., Cumbo T. J., Abrutin E., De Lattre M., Berbracht L. M. Gentamicin disposition and tissue accumulation on multiple dosing. Journal of Pharmacokinetics and Biopharmacology 1977; 5: 559–577
   PubMedGoogle Scholar
• Schneider W. J., Becker E. L. Acute transient hearing loss after ethacrynic acid therapy. Archives of Internal Medicine 1966; 117: 715–717
   PubMed Web of Science ®Google Scholar
• Schultz E. M., Cragoe E. J., Jr., Bicking J. B., Bolhoffer W. A., Sprague J. A. Alpha, beta-unsatu-rated ketone derivatives of aryloxyacetic acids, a new class of diuretics. Journal of Medical Pharmacology and Chemistry 1962; 5: 660 662.
   Google Scholar
• Schwartz G. H., David D. S., Riggio R. R., Stenzel K. H., Rubin A. L. Ototoxicity induced by furosemide. New England Journal of Medicine 1970; 282: 1413–1414
   PubMed Web of Science ®Google Scholar
• Sellars S. L. Acute deafness associated with depo-progesterone. Journal of Laryngology and Otology 1971; 85: 281–282
   PubMedGoogle Scholar
• Shenoi P. M. Ototoxicity of absorbable gelatin sponge. Proceedings of the Royal Society of Medicine 1973; 66: 193–196
   PubMedGoogle Scholar
• Silverstein H., Bernstein J. M., Davies D. G. Salicylate ototoxicity. A biochemical and electro-physiological study. Annals of Otology 1967; 76: 118–127
   PubMed Web of Science ®Google Scholar
• Simmons F. B., Glattke T. J., Downie D. B. Lidocaine in the middle ear: a unique cause of vertigo. Archives of Otolaryngology 1973; 98: 42–43
   PubMed Web of Science ®Google Scholar
• Sokabe M., Hayase J., Miyamoto K. Neo-mycin effect on the lysotriphosphoinositide channel as a model for an acute ototoxicity. Proceedings of the Japanese Academy, Series B 1982; 58: 177–180
   Web of Science ®Google Scholar
• Stebbins W.C, McGinns C. S., Feitosa M. A. G., Moody D. B., Prosen C. A., Serafin J. V. Animal models in the study of ototoxic hearing loss. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown and Company, Boston 1981; 5–25
   Google Scholar
• Strauss M., Towfighi J., Lord S., Lipton A., Harvey H. A., Brown B. Cis-platinum ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 1983; 93: 1554–1559
   PubMed Web of Science ®Google Scholar
• Tachibana M., Mizukoshi O., Kuriyama K. Inhibitory effects of kanamycin on glycolysis in cochlea and kidney—possible involvement in the formation of oto- and nephro-toxicities. Biochemical Pharmacology 1976; 25: 2297–2301
   PubMed Web of Science ®Google Scholar
• Takada A., Canlon B., Schacht J. Gentamicin ototoxicity dissociated from glucose uptake and utilization. Research Communications in Chemical Pathology and Pharmacology 1983; 42: 203–212
   PubMedGoogle Scholar
• Tibbling L. The influence of tobacco smoking, nicotine, CO, and CO2on vestibular nystagmus. Acta Oto-laryngologica 1969; 68: 118–126
   PubMed Web of Science ®Google Scholar
• Toone E. C., Jr., Hayden G. D., Ellman H. M. Ototoxicity of chlorquinine. Arthritis and Rheumatism 1965; 8: 475–476
   Web of Science ®Google Scholar
• Toyoda Y., Tachibana M. Tissue levels of kanamycin in correlation with oto- and nephro-toxicity. Acta Oto-laryngologica 1978; 86: 9–14
   PubMed Web of Science ®Google Scholar
• Tran Ba Huy P., Manuel C, Meulemans A., Sterkers O., Amiel C. Pharmacokinetics of gen-tamycin in perilymph and endolymph of the rat as determined by radioimmunoassay. Journal of Infectious Diseases 1981; 143: 476–486
   PubMed Web of Science ®Google Scholar
• Tsunoda Y. Ototoxicity of nitrogen mustard N-oxide. Journal of Oto laryngology of Japan 1970; 73: 581–599
   Google Scholar
• Vermorken J. B., Kapteijn T. S., Hart A. A. M., Pinedo H. M. Ototoxicity of cis-diammine-dichloroplatinum (II). Influence of dose, schedule and mode of administration. European Journal of Cancer and Clinical Oncology 1983; 19: 53–58
   PubMedGoogle Scholar
• Walike J. W., Snyder J. M. Recognizing and avoiding ototoxicity. Postgraduate Medicine 1972; 52: 141–145
   PubMed Web of Science ®Google Scholar
• Waltner J. The effect of salicylates on the inner ear. Annals of Otology 1955; 64: 617–622
   PubMedGoogle Scholar
• Watanabe Y., Nakajina R., Oda R., Uno M., Naito T. Experimental study on the transfer of kanamycin to inner ear fluids. Medical Journal of Osaka University 1971; 21: 257–263
   PubMedGoogle Scholar
• Weiner N. D., Schacht J. Biochemical model of aminoglycoside-induced hearing loss. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown and Company, Boston 1981; 113–121
   Google Scholar
• Wersall C. A. Structural damage to the organ of Corti and the vestibular epithelia caused by aminoglycoside antibiotics in the guinea pig. Aminoglycoside Ototoxicity, S. A. Lerner, G. J. Matz, J. E. Hawkins, Jr. Little, Brown and Company, Boston 1981; 197–214
   Google Scholar
• West B. A., Brummett R. E., Himes D. L. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Archives of Oto-laryngology 1973; 98: 32–37
   PubMedGoogle Scholar
• Whelton A., Solez K. Pathophysiologic mechanisms in aminoglycoside nephrotoxicity. Journal of Clinical Pharmacology 1983; 23: 453–460
   PubMed Web of Science ®Google Scholar
• Wright C. G., Schaefer S. D. Inner ear histo-pathology in patients treated with cis-platinum. Laryngoscope 1982; 92: 1408–1413
   PubMed Web of Science ®Google Scholar
• Wright P. Untoward effects associated with prac-tolol administration: oculomucocutaneous syndrome. British Medical Journal 1975; 1: 595–598
   PubMed Web of Science ®Google Scholar